National Guideline Clearinghouse
National Guideline Clearinghouse (NGC) was a database of evidence-based clinical practice guidelines, sponsored by the Agency for Healthcare Research and Quality (AHRQ), part of the United States Department of Health and Human Services. The NGC was created in 1998 and ceased operations in July 2018 due to federal funding cuts.
Overview[edit]
The National Guideline Clearinghouse was a public resource for summaries of evidence-based clinical practice guidelines. The NGC used inclusion criteria to ensure that the guidelines in the database were of high quality, based on a systematic review of the evidence. The database included guidelines developed by medical specialty societies, professional associations, and government agencies.
History[edit]
The National Guideline Clearinghouse was established in 1998 by the Agency for Healthcare Research and Quality (AHRQ), in partnership with the American Medical Association and the American Association of Health Plans (now America's Health Insurance Plans). The goal of the NGC was to provide physicians and other health professionals, health care providers, health plans, integrated delivery systems, purchasers, and others an accessible mechanism for obtaining objective, detailed information on clinical practice guidelines and to further their dissemination, implementation, and use.
In July 2018, the NGC was shut down due to federal funding cuts. The website was taken offline and the database is no longer accessible.
Impact[edit]
The National Guideline Clearinghouse was a valuable resource for healthcare professionals and researchers. It provided a centralized location for accessing and comparing guidelines from different organizations. The NGC also provided a standardized format for presenting guidelines, making it easier to compare and contrast different guidelines.
See also[edit]
References[edit]
<references />
-
Logo of the National Guideline Clearinghouse
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
